Novartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing Director

Sanjay Murdeshwar is Country President, Novartis in India and responsible for the company's pharmaceuticals business in the country.

New Delhi: Pharma firm Novartis India recently announced the appointment of Sanjay Murdeshwaras vice chairman and managing director of the company.

"..based on recommendation of the Nomination and Remuneration Committee of the Board, the Board of Directors of Novartis lndia Ltd at their meeting held today, have approved the appointment of Sanjay Murdeshwar as Vice Chairman & Managing Director of the Company effective June 15, 2019, subject to the approval of Shareholders and Central Government," a company statement said.

Also Read: Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

Murdeshwar is Country President, Novartis in India and responsible for the company's pharmaceuticals business in the country.

He is also managing director of Novartis Healthcare Private Ltd. Murdeshwar comes with more than 20 years of experience in the healthcare industry which includes varied roles in the pharmaceuticals and consumer health businesses, it added.

Drugmaker, Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol) valsartan (Diovan),imatinib mesylate (Gleevec/Glivec), ciclosporin (Neoral/Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others.

Also Read: Novartis' secret settlement talks revealed in accidental filing: Bloomberg Report